<?xml version="1.0" encoding="UTF-8"?>
<ref id="b13-1031654">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Knapper</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Russell</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Gilkes</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML</article-title>. 
  <source>Blood</source>. 
  <year>2017</year>; 
  <volume>129</volume>(
  <issue>9</issue>):
  <fpage>1143</fpage>â€“
  <lpage>1154</lpage>.
  <pub-id pub-id-type="pmid">27872058</pub-id>
 </mixed-citation>
</ref>
